original ) (raw )Association of acquired von Willebrand syndrome with AL amyloidosis
Vaishali Sanchorawala
American Journal of Hematology, 2007
View PDFchevron_right
Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis
Evan Vosburgh
Bone Marrow Transplantation, 2001
View PDFchevron_right
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy
Alex Herrera
Bone marrow transplantation, 2016
View PDFchevron_right
Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis – A Single Institution 11 Year Experience
Richard Maziarz
SPG BioMed
View PDFchevron_right
Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis
Vaishali Sanchorawala
Bone Marrow Transplantation, 2005
View PDFchevron_right
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis
Marco Basset
Blood Advances
View PDFchevron_right
Outcome of Patients with Immunoglobulin Light Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation
Omar Fakih
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015
View PDFchevron_right
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant
Nelson Leung
European Journal of Haematology, 2014
View PDFchevron_right
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis
Martha Lacy
Bone Marrow Transplantation, 2001
View PDFchevron_right
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center
William Hogan
Bone Marrow Transplantation, 2013
View PDFchevron_right
Erratum: Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis
Michael Lavalley
Bone Marrow Transplantation, 2005
View PDFchevron_right
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis
Tadashi Tomo
American Journal of Hematology, 2006
View PDFchevron_right
Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis
Nelson Leung
Blood, 2017
View PDFchevron_right
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
William Hogan
Leukemia & Lymphoma, 2010
View PDFchevron_right
Deferred autologous stem cell transplantation in systemic AL amyloidosis
charalampia Kyriakou
Blood Cancer Journal, 2018
View PDFchevron_right
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients
Mohamed Amin
British Journal of Haematology, 1998
View PDFchevron_right
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis
Hasib Sidiqi
Biology of Blood and Marrow Transplantation, 2018
View PDFchevron_right
AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
Nita Williams
Journal of Clinical Medicine, 2020
View PDFchevron_right
Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study
F. Abar
Clinical Lymphoma Myeloma and Leukemia, 2014
View PDFchevron_right
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis
Hasib Sidiqi
Biology of Blood and Marrow Transplantation, 2018
View PDFchevron_right
Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura
D. Damiani , M. Baccarani
Bone Marrow Transplantation, 1999
View PDFchevron_right
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis
Nelson Leung
American Journal of Hematology, 2012
View PDFchevron_right
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
Marco Bregni
2006
View PDFchevron_right
Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis
William Fleming
Bone Marrow Transplantation, 2002
View PDFchevron_right
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation
Veronique Leblond , Augustin Ferrant
Blood, 2006
View PDFchevron_right